India · Delayed Price · Currency is INR Indrayani Biotech Statistics
Total Valuation
BOM:526445 has a market cap or net worth of INR 370.67 million. The enterprise value is 1.90 billion.
| Market Cap | 370.67M |
| Enterprise Value | 1.90B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:526445 has 45.54 million shares outstanding. The number of shares has decreased by -12.71% in one year.
| Current Share Class | 45.54M |
| Shares Outstanding | 45.54M |
| Shares Change (YoY) | -12.71% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 57.60% |
| Owned by Institutions (%) | 3.66% |
| Float | 19.17M |
Valuation Ratios
The trailing PE ratio is 49.17.
| PE Ratio | 49.17 |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| PB Ratio | 0.35 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | 1.51 |
| P/OCF Ratio | 1.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.21, with an EV/FCF ratio of 7.96.
| EV / Earnings | 250.72 |
| EV / Sales | 1.29 |
| EV / EBITDA | 21.21 |
| EV / EBIT | 43.17 |
| EV / FCF | 7.96 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.71 |
| Quick Ratio | 0.68 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 14.40 |
| Debt / FCF | 5.40 |
| Interest Coverage | 0.50 |
Financial Efficiency
Return on equity (ROE) is 2.14% and return on invested capital (ROIC) is 1.94%.
| Return on Equity (ROE) | 2.14% |
| Return on Assets (ROA) | 1.28% |
| Return on Invested Capital (ROIC) | 1.94% |
| Return on Capital Employed (ROCE) | 3.32% |
| Weighted Average Cost of Capital (WACC) | 5.52% |
| Revenue Per Employee | 1.56M |
| Profits Per Employee | 8,053 |
| Employee Count | 936 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.38 |
Taxes
| Income Tax | -18.64M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.93% in the last 52 weeks. The beta is 0.30, so BOM:526445's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -48.93% |
| 50-Day Moving Average | 8.87 |
| 200-Day Moving Average | 9.15 |
| Relative Strength Index (RSI) | 46.17 |
| Average Volume (20 Days) | 42,657 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:526445 had revenue of INR 1.46 billion and earned 7.54 million in profits. Earnings per share was 0.17.
| Revenue | 1.46B |
| Gross Profit | 410.72M |
| Operating Income | 43.78M |
| Pretax Income | 6.80M |
| Net Income | 7.54M |
| EBITDA | 89.12M |
| EBIT | 43.78M |
| Earnings Per Share (EPS) | 0.17 |
Balance Sheet
The company has 42.56 million in cash and 1.28 billion in debt, with a net cash position of -1.24 billion or -27.24 per share.
| Cash & Cash Equivalents | 42.56M |
| Total Debt | 1.28B |
| Net Cash | -1.24B |
| Net Cash Per Share | -27.24 |
| Equity (Book Value) | 1.02B |
| Book Value Per Share | 16.01 |
| Working Capital | 657.39M |
Cash Flow
In the last 12 months, operating cash flow was 316.54 million and capital expenditures -79.05 million, giving a free cash flow of 237.49 million.
| Operating Cash Flow | 316.54M |
| Capital Expenditures | -79.05M |
| Depreciation & Amortization | 45.35M |
| Net Borrowing | -71.50M |
| Free Cash Flow | 237.49M |
| FCF Per Share | 5.22 |
Margins
Gross margin is 28.05%, with operating and profit margins of 2.99% and 0.51%.
| Gross Margin | 28.05% |
| Operating Margin | 2.99% |
| Pretax Margin | 0.46% |
| Profit Margin | 0.51% |
| EBITDA Margin | 6.09% |
| EBIT Margin | 2.99% |
| FCF Margin | 17.23% |
Dividends & Yields
BOM:526445 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 12.71% |
| Shareholder Yield | 12.71% |
| Earnings Yield | 2.03% |
| FCF Yield | 66.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |